Alkermes short bets built up ahead of depression drug setback

NEW YORK, Jan 28 (Reuters) - Investors who recently shorted Alkermes Plc shares may have had their timing exactly right: They stood to make a nice profit when a setback caused the stock to drop 44 percent.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.